ASTELLAS PHARMA, S.A. secures contract for Pharmaceutical products - Supply of the medicines Enzalutamide 40 mg tablet and Tacrolimus 5 mg/ml injectable perfusion 1 ml, exclusive medicines marketed by Astellas Pharma, SA, destined for centers dependent on the Health Service of the Balearic Islands

Spain, Oct. 12 -- Spain based ASTELLAS PHARMA, S.A. has secured contract from Servicio de Salud de las Illes Balears for Pharmaceutical products - Supply of the medicines Enzalutamide 40 mg tablet and Tacrolimus 5 mg/ml injectable perfusion 1 ml, exclusive medicines marketed by Astellas Pharma, SA, destined for centers dependent on the Health Service of the Balearic Islands. The value of the contract is worth 3512502.5 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....